MenQuadfi
NDC 49281-590, NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, injection, solution, from Sanofi Vaccines US Inc..
- Product NDC
- 49281-590
- Status
- Listed
- Labeler
- Sanofi Vaccines US Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125701
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49281-590 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN10 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN10 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN10 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN10 ug/.5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49281-590-01 | 49281059001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-01) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58) |
| 49281-590-05 | 49281059005 | 5 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-05) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58) |
| 49281-590-10 | 49281059010 | 10 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-10) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 49281-590 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49281-590 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49281-590. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.